Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Glatting

Showing results (71-80 of 150) with videos related to

Pageof 15
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|March 3, 2004
Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancerHolger Schirrmeister, Coskun Arslandemir, Gerhard Glatting, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|February 17, 2024
A PBPK model for PRRT with [<sup>177</sup>Lu]Lu-DOTA-TATE: Comparison of model implementations in SAAM II and MATLAB/SimBiologyValentina Vasić, Johan Gustafsson, Elham Yousefzadeh Nowshahr, et al.
Medical Physics|May 6, 2004
Improving binding potential analysis in [11C]raclopride PET studies using cluster analysisGerhard Glatting, Felix M Mottaghy, Jochen Karitzky, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 23, 2002
Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[(18)F]fluoro-3'-deoxythymidine ([(18)F]FLT) in pancreatic cancer cell linesUlrike Seitz, Martin Wagner, Bernd Neumaier, et al.
Nuclear Medicine and Biology|October 11, 2011
Auger electron emitter against multiple myeloma--targeted endo-radio-therapy with 125I-labeled thymidine analogue 5-iodo-4'-thio-2'-deoxyuridineAgnieszka Morgenroth, Cornelia Dinger, Boris D Zlatopolskiy, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 22, 2021
Mathematical Modeling of <i>In Vivo</i> Alpha Particle Generators and Chelator StabilityNouran R R Zaid, Peter Kletting, Ambros J Beer, et al.
Cancer Research|March 3, 2007
Breaking chemoresistance and radioresistance with [213Bi]anti-CD45 antibodies in leukemia cellsClaudia Friesen, Gerhard Glatting, Bernd Koop, et al.
Plos One|May 21, 2015
Image-Guided Radiotherapy Using a Modified Industrial Micro-CT for Preclinical ApplicationsManuela C Felix, Jens Fleckenstein, Stefanie Kirschner, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Towards to hENT1-nucleoside transporter selective imaging agents. Synthesis and in vitro evaluation of the radiolabeled SAENTA analoguesBoris D Zlatopolskiy, Agnieszka Morgenroth, Elizaveta A Urusova, et al.
Plos One|September 10, 2016
Investigating the Effect of Ligand Amount and Injected Therapeutic Activity: A Simulation Study for 177Lu-Labeled PSMA-Targeting PeptidesPeter Kletting, Christiane Schuchardt, Harshad R Kulkarni, et al.
Pageof 15

Showing results (71-80 of 150) with videos related to

Sort By:
Pageof 15
European Journal of Nuclear Medicine and Molecular Imaging|March 3, 2004
Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancerHolger Schirrmeister, Coskun Arslandemir, Gerhard Glatting, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|February 17, 2024
A PBPK model for PRRT with [<sup>177</sup>Lu]Lu-DOTA-TATE: Comparison of model implementations in SAAM II and MATLAB/SimBiologyValentina Vasić, Johan Gustafsson, Elham Yousefzadeh Nowshahr, et al.
Medical Physics|May 6, 2004
Improving binding potential analysis in [11C]raclopride PET studies using cluster analysisGerhard Glatting, Felix M Mottaghy, Jochen Karitzky, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 23, 2002
Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[(18)F]fluoro-3'-deoxythymidine ([(18)F]FLT) in pancreatic cancer cell linesUlrike Seitz, Martin Wagner, Bernd Neumaier, et al.
Nuclear Medicine and Biology|October 11, 2011
Auger electron emitter against multiple myeloma--targeted endo-radio-therapy with 125I-labeled thymidine analogue 5-iodo-4'-thio-2'-deoxyuridineAgnieszka Morgenroth, Cornelia Dinger, Boris D Zlatopolskiy, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 22, 2021
Mathematical Modeling of <i>In Vivo</i> Alpha Particle Generators and Chelator StabilityNouran R R Zaid, Peter Kletting, Ambros J Beer, et al.
Cancer Research|March 3, 2007
Breaking chemoresistance and radioresistance with [213Bi]anti-CD45 antibodies in leukemia cellsClaudia Friesen, Gerhard Glatting, Bernd Koop, et al.
Plos One|May 21, 2015
Image-Guided Radiotherapy Using a Modified Industrial Micro-CT for Preclinical ApplicationsManuela C Felix, Jens Fleckenstein, Stefanie Kirschner, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Towards to hENT1-nucleoside transporter selective imaging agents. Synthesis and in vitro evaluation of the radiolabeled SAENTA analoguesBoris D Zlatopolskiy, Agnieszka Morgenroth, Elizaveta A Urusova, et al.
Plos One|September 10, 2016
Investigating the Effect of Ligand Amount and Injected Therapeutic Activity: A Simulation Study for 177Lu-Labeled PSMA-Targeting PeptidesPeter Kletting, Christiane Schuchardt, Harshad R Kulkarni, et al.
Pageof 15